By taking into account the confirmed greater efficacy of combined treatment CXL+ICRS, its staged use with TG-PRK is supposed to be the most optimal option in the treatment of keratoconus: CXL+ICRS as the first stage and TG-PRK as the second stage. This evidence concerns the gene PLK3 and keratoconus.